Skip to main content
August 12, 2026

The Immortal Life of Henrietta Lacks Discussion Questions

The Immortal Life of Henrietta Lacks doesn't have a twist to spoil or a protagonist who changes across three acts — Henrietta is dead well before the book's midpoint, and the rest of its 381 pages trace what happened to her cells instead of what happened to her. That structural choice is exactly why it's one of the better books to hand a club that's tired of the "what did you think of the ending" conversation. There's no ending to summarize. There's only an argument about consent, race, and who owns a body once part of it leaves the room — and that argument is still legally unresolved sixteen years after the book's publication.

Some of the history is worth stating plainly before a club opens the book, because it's easy to soften in conversation. Henrietta Lacks was a Black tobacco farmer and mother of five living outside Baltimore when she was diagnosed with cervical cancer at Johns Hopkins Hospital in 1951 — at the time, one of the only hospitals in the region that would treat Black patients at all, and only on segregated charity wards. During a biopsy, her surgeon took tissue samples from her tumor without telling her; she never knew, and never consented. She died on October 4, 1951, at 31. The cells taken from her tumor, cultured by researcher George Gey and named "HeLa" after the first two letters of her first and last name, turned out to be the first human cells that would survive and multiply indefinitely outside the body — the first cell line of its kind. They've since been used to help develop the polio vaccine, map the human genome, test the effects of radiation and toxic substances, and research treatments ranging from HPV to COVID-19. Her family didn't learn the cells existed until 1973, when scientists contacted them for blood samples to study the line's genetic markers; confused, the family believed they were being tested for cancer themselves.

Rebecca Skloot spent close to a decade reporting the book before Crown published it in February 2010. It won the Chicago Tribune Heartland Prize for Nonfiction, the Wellcome Trust Book Prize, and the AAAS/Subaru SB&F Prize for Excellence in Science Books (Young Adult category), then the National Academies Communication Award in 2011, and spent well over a year on the New York Times bestseller list. HBO adapted it into a film that premiered in April 2017, with Oprah Winfrey playing Henrietta's daughter Deborah Lacks and Rose Byrne playing Skloot. None of that is why clubs still pick it up now. They pick it up because the questions the book raises didn't get settled by its ending. In 2013, a German research team published the full HeLa genome sequence publicly without asking the family, which forced the NIH to negotiate a controlled-access agreement that seated two Lacks family members on the review panel. In 2023, the family settled a lawsuit against Thermo Fisher Scientific over the company's continued commercial sale of HeLa-derived products; the terms are confidential. The book describes a fight that is still, right now, generating lawsuits.

The strongest discussion questions for The Immortal Life of Henrietta Lacks skip plot recap entirely and go straight at what clubs actually disagree about: whether Henrietta's cells should have required her consent given the norms of 1951, whether Johns Hopkins and the institutions that profited owe the Lacks family more than an acknowledgment, and whether Rebecca Skloot herself — a science journalist who built her career reporting a Black family's history of medical exploitation — resolved the book's central problem or found a new way to repeat it.

What Henrietta Never Knew

Consent is where every club ends up first, and it's worth slowing down on rather than settling in the first five minutes.

  1. In 1951, informed consent as it's practiced today didn't exist as a legal or medical standard — doctors routinely used patients' tissue for research without asking. Does that historical context change how you judge what happened to Henrietta, or does it mostly explain why nobody was ever held accountable for it?
  2. Henrietta's real name and medical history were published years before her family had any say in the matter, and Skloot argues that journalists and scientists alike treated her privacy as secondary to the public's right to know about a scientific breakthrough. Does a person whose cells outlive them by decades still have a privacy interest worth protecting?
  3. George Gey, the researcher who cultured HeLa, never patented the cells or personally profited — he mailed samples to any lab that requested them, believing science should be shared freely. Does his lack of personal profit make the original taking more forgivable, or does it just relocate the exploitation further down the chain?
  4. The book contrasts what happened to Henrietta with modern biobanking, where patients sign consent forms for tissue research most people never read closely. Has consent law actually solved the problem the book describes, or has it mostly given the same problem better paperwork?

Segregated Wards, Shared Science

The book keeps returning to Johns Hopkins as both the villain of the story and the only hospital that would see Henrietta at all — that contradiction is worth sitting with rather than resolving quickly.

  1. Henrietta was treated at Johns Hopkins specifically because it was one of the only hospitals in the region willing to treat Black patients, and only in a segregated charity ward. What does it mean that the hospital praised in the book for its charity care is the same one that took her cells without asking?
  2. Skloot spends real time on the Lacks family's later encounters with medicine, including Henrietta's daughter Elsie, who died in a segregated Maryland institution for Black patients with epilepsy and mental illness, and family members decades later who couldn't get straight answers from doctors about their own health. Does that read to your club as a string of isolated incidents, or as one continuous institutional pattern?
  3. Johns Hopkins has since issued public statements acknowledging its historical failures toward the Lacks family and has funded scholarships and building dedications in Henrietta's name. Does an acknowledgment more than sixty years later count as accountability, or does it function more like reputation management?
  4. Rebecca Skloot founded the Henrietta Lacks Foundation, funded in part by proceeds from the book itself, to give financial assistance to Lacks descendants and to other families whose tissue was used in research without consent or payment. Does a private foundation funded by book royalties strike your club as an adequate substitute for what Hopkins and the broader research industry never did?

Who Gets to Profit

This is the section where the numbers do the arguing, so it's worth having them straight before the club gets going.

  1. HeLa cells have been bought and sold commercially for decades — companies have built substantial research-supply businesses on a cell line descended directly from Henrietta's tumor — while her family lived for years without the means to pay for their own medical care. What should profiting from a person's cells actually obligate a company to do for that person's descendants?
  2. In August 2023, the Lacks family settled a lawsuit against Thermo Fisher Scientific over its continued sale of HeLa-derived products, and the settlement terms were kept confidential. Does a private, undisclosed settlement feel like resolution to your club, or does confidentiality just move the same information imbalance the book describes into a new form?
  3. In 2013, a research team published Henrietta's full genome online without the family's knowledge, which also exposed genetic information about her living descendants. The NIH then negotiated a data-access agreement that seated two Lacks family members on a review panel deciding who gets to use it. Is a seat on a review panel meaningful control over the science, or a symbolic one?

Whose Story Was This to Tell

The last argument worth having is about the book itself, not just its subject — and it's the one clubs tend to skip because it points the question back at the reader.

  1. Skloot is a white science journalist who spent nearly a decade reporting on a Black family's history of medical exploitation, and the book made her career. Does the book earn the trust it asks the Lacks family — and the reader — to extend to it, or does it repeat some version of the extraction it's describing?
  2. Deborah Lacks, Henrietta's daughter, is as much the emotional center of the book as Henrietta herself — her search to understand the mother she never really knew, and her fear that she or her family might be studied without their knowledge too. Did the book need Deborah's arc to make Henrietta's story land, or does centering Deborah's grief risk becoming its own kind of use of the family's pain?
  3. The book doesn't offer a tidy resolution — the Lacks family's relationship with Hopkins and the broader research establishment is still unsettled, still generating lawsuits more than a decade after publication. Did that open ending feel honest to your club, or did the book owe its subjects a clearer verdict?

None of this requires anyone in the room to have a background in bioethics. It requires the same thing every good nonfiction pick requires, which is a subject nobody in the club can fully resolve by the time the meeting ends. If this one worked for your group, the best nonfiction books for book clubs list has more titles built the same way — real stakes, no tidy ending. And if the ethics conversation started strong but wandered, the guide to running better book club discussions has specific tactics for keeping an argument about ideas from turning into a lecture from whoever read the most Wikipedia pages beforehand. For a different angle on the same territory — one voice instead of a whole family carrying the weight — the best memoirs for book clubs roundup pairs well with this pick.

Found a book that actually gave your club something to fight about?

That's the bet behind Picked Together — a two-minute quiz that matches your club to books people want to argue over, not just finish and forget.

Get Your Club's Next Pick